2025 Annual Meeting | S6 - Sleep
Program Materials Program Evaluations
Anne M. Morse, DO | Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Morse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Morse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alkermes. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Avadel. Dr. Morse has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Harmony biosciences. Dr. Morse has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Hayes solicitors. Dr. Morse has received publishing royalties from a publication relating to health care. Dr. Morse has received personal compensation in the range of $100,000-$499,999 for serving as a CEO with DAMM Good Sleep, LLC. |
Pablo R. Castillo, MD, FAAN | Dr. Castillo has nothing to disclose. |
Mark I. Boulos, MD, FRCPC, CSCN(EEG), MSc | Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision AQ. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sleep Medicine (journal). The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from Slamen-Fast New Initiatives in Neurology Award. The institution of Dr. Boulos has received research support from Green Mountain . The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and 好色先生 in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. The institution of Dr. Boulos has received research support from StrokeCog. The institution of Dr. Boulos has received research support from McLaughlin Centre for Molecular Medicine . Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Jazz Pharmaceuticals. |
Stephen Joza, MD, PhD | Dr. Joza has nothing to disclose. |
Abidemi Otaiku, MD | Dr. Otaiku has nothing to disclose. |
Neha V. Reddy | Miss Reddy has nothing to disclose. |
Michael J. Howell, MD, FAAN | Dr. Howell has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for GEM Health. Dr. Howell has stock in Sleep Performance Institute. The institution of Dr. Howell has received research support from National Institutes of Health. Dr. Howell has received publishing royalties from a publication relating to health care. |
Meaghan Berns, MD | Dr. Berns has nothing to disclose. |
Erjia Cui | Dr. Cui has nothing to disclose. |
DANIEL S. LLOYD | Mr. LLOYD has received personal compensation for serving as an employee of UCB. |
Alexis Davis, MS | Ms. Davis has nothing to disclose. |
Michael McLinden | No disclosure on file |
John van Zyl | Mr. van Zyl has received personal compensation for serving as an employee of UCB. |
Stefanie Dedeurwaerdere, PhD | Mrs. Dedeurwaerdere has received personal compensation for serving as an employee of UCB Pharma. Mrs. Dedeurwaerdere has stock in UCB Pharma. Mrs. Dedeurwaerdere has received intellectual property interests from a discovery or technology relating to health care. |
Amelie Lothe, PhD | Dr. Lothe has received personal compensation for serving as an employee of UCB. Dr. Lothe has stock in UCB. |
CHRIS CLARK | Mr. CLARK has received personal compensation for serving as an employee of UCB. |
Dana Y. Teltsch, PhD | Dr. Teltsch has received personal compensation for serving as an employee of Takeda. Dr. Teltsch has stock in Takeda. |
Bonnie K. Bui, PhD | Dr. Bui has received personal compensation for serving as an employee of Optum. Dr. Bui has stock in UNH. |
Amy Anderson | Ms. Anderson has received personal compensation for serving as an employee of AstraZeneca. Ms. Anderson has received personal compensation for serving as an employee of Optum. Ms. Anderson has stock in UnitedHealth Group. |
Stephen Crawford, PhD | Dr. Crawford has received personal compensation for serving as an employee of Takeda. Dr. Crawford has stock in Takeda. |
Amy Duhig, PhD | Dr. Duhig has received personal compensation for serving as an employee of Takeda . Dr. Duhig has stock in Takeda. |
Brandon Diessner, PhD | Dr. Diessner has received personal compensation for serving as an employee of Optum. Dr. Diessner has stock in UnitedHealth Group. |
Phani Veeranki, MD, DrPH | Dr. Veeranki has received personal compensation for serving as an employee of Optum . Dr. Veeranki has stock in Optum. |
Yelena G. Pyatkevich | No disclosure on file |
Azka Ijaz, MBBS | Miss Ijaz has nothing to disclose. |
Mohammad Ammar Ur Rahman, MBBS | Dr. Ammar Ur Rahman has nothing to disclose. |
Luqman Munir | Mr. Munir has nothing to disclose. |
Sara Sohail | Sara Sohail has nothing to disclose. |
Jennifer L. Marsella, MD | Dr. Marsella has nothing to disclose. |
Cynthia Gibson, NP | Ms. Gibson has received personal compensation in the range of $0-$499 for serving as a Consultant for Amylx. |
Emma Ciafaloni, MD, FAAN | Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care. |
Scott McIntosh, PhD | Dr. McIntosh has nothing to disclose. |
Reza Y. Yousefi Nooraie, PhD | Dr. Yousefi Nooraie has nothing to disclose. |
Jyothsna Ravula | No disclosure on file |
Satish Jetta | Satish Jetta has received intellectual property interests from a discovery or technology relating to health care. |
Vinod Goyal | Vinod Goyal has received intellectual property interests from a discovery or technology relating to health care. |
Veera Raghava Chowdary Palacharla, Scientist | Mr. Palacharla has stock in Suven Life Sciences Limited. Mr. Palacharla has received intellectual property interests from a discovery or technology relating to health care. |
Vijay Benade | Vijay Benade has nothing to disclose. |
Anil Shinde | Anil Shinde has received intellectual property interests from a discovery or technology relating to health care. |
Renny Abraham, PhD | Mr. Abraham has nothing to disclose. |
Santosh Pandey, MVSc, DABT | Mr. Pandey has nothing to disclose. |
Ramkumar S, Chief Scientist | Mr. S has nothing to disclose. |
Abdul Rasheed Mohammed, PhD | Mr. Mohammed has nothing to disclose. |
Pradeep Jayarajan, PhD | Pradeep Jayarajan has received personal compensation for serving as an employee of Suven Life Sciences Ltd. Pradeep Jayarajan has stock in Suven Life Sciences. Pradeep Jayarajan has received intellectual property interests from a discovery or technology relating to health care. |
Venkat Jasti | Venkat Jasti has stock in Suven Life Sciences Ltd. Venkat Jasti has received intellectual property interests from a discovery or technology relating to health care. |
Ramakrishna Nirogi, PhD | Dr. Nirogi has nothing to disclose. |